期刊文献+

肿瘤坏死因子相关凋亡诱导配体在再生障碍性贫血患者中的表达及意义

Expression and significance of tumor necrosis factor-related apoptosis-inducing ligand in aplastic anemia
下载PDF
导出
摘要 目的通过检测再生障碍性贫血(AA)患者骨髓单个核细胞表面肿瘤坏死因子相关凋亡诱导配体(TRAIL)的表达,探讨TRAIL在AA造血干细胞凋亡中的作用。方法采用流式细胞术对12例AA患者(AA组)、11例AA治疗后缓解患者(缓解组)、12例正常对照者(对照组)骨髓单个核细胞表面TRAIL的表达进行检测。结果 AA组、缓解组、对照组TRAIL均有表达;AA组TRAIL的阳性表达率(5.8±3.3)%高于缓解组(2.4±2.0)%和对照组(3.2±2.2)%(P<0.05);缓解组与对照组间差异无统计学意义(P>0.05)。结论 TRAIL在AA患者骨髓单个核细胞表面的表达阳性率增高,提示TRAIL介导的细胞凋亡可能在AA的发病机制中发挥一定的作用。 Objective- To detect the expression of tumor necrosis factor-related apoptosis-inducing ligand @RAIL) on the surface of mononuclear cells in patients with aplastic anemia (AA), and to investigate the effects of TRAIL on the apoptosis of hemopoietic stem cells. Methods The flow cytometry was employed to detect the expres- sion of TRAIL on the bone marrow mononuelear cells in 12 patients with AA (AA group), 11 patients with remission of AA (remission group) and 12 normal subjects (control group). Results TRAIL was expressed in these three groups. The level of TRAIL expression in AA group (5.8±3.3)% was markedly higher than that in remission group (2.4±2.0)% and control group (3.2±2.2)% (P〈0.05), with no significant difference being shown between the latter two groups (P〉 0.05). Conclusion The expression of TRAIL is augmented on the surface of bone marrow mononuclear cells, suggest- ing that the associated apoptosis may have played a role in the pathogenesis of AA.
出处 《中国药物与临床》 CAS 2014年第2期160-162,共3页 Chinese Remedies & Clinics
基金 太原市科技项目(11027608)
关键词 贫血 再生障碍性 肿瘤坏死因子相关凋亡诱导配体 流式细胞术 Anemia, aplastic Tumor necrosis factor-related apoptosis-inducing ligand Flow cytometry
  • 相关文献

参考文献17

  • 1陆再英;钟南山;谢毅.内科学[M]北京:人民卫生出版社,2009578-581.
  • 2Zheng M,Zheng K,Zhou J. Tcf-1 gene silence suppresses downstream gene expression in CD4(+)T cell from bone marrow of aplastic anemia patients[J].{H}Annals of Hematology,2012,(3):353-358.
  • 3Maciejewski JP,Selleri C,Anderson S. Fas antigen expres-sion on CD34+ human marrow cells is induced by interferongam-ma and tumor necrosis factor-alpha and potentiates hematopoietic suppression in vitro[J].{H}Blood,1995.3183-3190.
  • 4Wiley SR,Schooley K,Cmolak PJ. Identification and char-acterization of a new member of the TNF family that induce apoptosis[J].{H}IMMUNITY,1995,(6):673-682.
  • 5张之南;沈悌.血液病诊断及疗效标准[M]北京:科学出版社,200719-23.
  • 6Kakagianni T,Giannakoulas NC,Thanopoulou E. A proba-ble role for trail-induced apoptosis in the pathogenesis of marrow failure.Implications from an in vitro model and from marrow of aplastic anemia patients[J].{H}Leukemia Research,2006,(6):713-721.
  • 7Marsters SA,Pitti RA,Sheridan JP. Control of apoptosis signaling by Apo2 ligand[J].{H}Recent Progress in Hormone Research,1999.225-234.
  • 8Kim Y,Seol DW. TRAIL,a mighty apoptosis inducer[J].{H}Molecules and Cells,2003,(3):283-293.
  • 9Huang L,Xu J,Li K. Thap sigargin potentiates TRA IL-in-duced apoptosis in giant cell tumor of bone[J].{H}BONE,2004,(6):971-981.
  • 10Gliniak B,Le T. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemother-apeutic agent CPT211[J].{H}CANCER RESEARCH,1999,(24):6153-6158.

二级参考文献13

  • 1赵湜,王红祥,毛红,肖娟,邹萍.肿瘤坏死因子相关凋亡诱导配体TRAIL及其受体在急性髓系白血病细胞中的表达及意义[J].中国实验血液学杂志,2005,13(1):65-69. 被引量:13
  • 2RaymondADANIELS,HelenTURLEY,FionaCKIMBERLEY,XueSongLIU,JuthathipMONGKOLSAPAYA3,PaulCH'EN,XiaoNingXU,BoquanJIN,FrancescoPEZZELLA,GavinRSCREATON.Expression of TRAIL and TRAIL receptors in normal and malignant tissues[J].Cell Research,2005,15(6):430-438. 被引量:22
  • 3姚悦萍,欧阳健,陈震章,侯亚义.肿瘤坏死因子相关的凋亡诱导配体受体在白血病细胞中的表达及其意义[J].临床内科杂志,2006,23(5):348-350. 被引量:5
  • 4Brodsky RA,Jones RJ.Aplastic anaemia.Lancet,2005,365(9471):1647-1656.
  • 5Wiley SR,Schooley K,Cmolak PJ,et al.Identification and characterization of a new member of the TNF family that induce apoptesis.Immunity.1995(6):673-682.
  • 6Truneh A,Sharma S,Silverman C,et al.Temperature-sensitive differential affinity of TRAIL for its receptors.DR5 is the highest affinity receptor.J Biol Chem,2000,275(30):23319-23325.
  • 7Ceisshr K.Pathophysiology and treatment of aplastic anemia.Wiener Klinniche Wochenschrift,2003,115(13214):444-450.
  • 8Kaito K,Otsubo H,Usui N,et al.Th1 /Th2 lymphocyte balance in patients with aplastic anemia.J Clin Pathol,2004,52(7):569-573.
  • 9Kakagianni T.Giannakoulns NC,Thanopoulou E,et al.A probable role for trail-induced apoptosis in the pathogenesis of marrow failure.Implications from an in vitro model and from marrow of aplastic anemia patients.Leuk Res,2006,30(6):713-721.
  • 10Kim Y,Seol DW.TRAIL,a mighty apoptesis inducer.Mol Cells,2003,15(3):283-293.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部